CINT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CI&T Inc is not a good buy right now for a beginner long-term investor who wants to deploy capital immediately. The stock has improving fundamentals, but the current price action is weak, the technical trend is bearish, and there is no strong proprietary buy signal. For a patient investor, the better choice is to wait for a clearer reversal or a pullback closer to support before buying.
The trend is currently bearish. MACD histogram is negative and still contracting, RSI_6 at 39.15 shows weak but not oversold momentum, and the moving averages are stacked bearishly with SMA_200 > SMA_20 > SMA_5. Price at 3.99 is below the pivot at 4.105 and only slightly above first support at 3.879, which means the stock is trading near support but has not confirmed a reversal. Short-term pattern data also suggests limited upside next week and a slightly negative one-month outlook.
Revenue in 2025/Q4 grew 19.61% YoY, net income rose 38.73% YoY, and EPS increased 37.50% YoY, showing solid business momentum. Wedbush initiated coverage with an Outperform rating and a $9 price target, highlighting CI&T's role in AI and cloud transformation. The next earnings release is scheduled for 2026-05-11 after hours, with consensus EPS estimated at 0.09, which could act as a catalyst if results beat expectations.
There has been no recent news in the past week, so there is no fresh event-driven catalyst. The latest quarter also showed gross margin contraction to 32.26%, down 8.72% YoY, which is a concern. JPMorgan recently lowered its price target to $6 from $7 and warned about weak discretionary IT spending. No recent congress or insider trading activity stands out as a catalyst.
In 2025/Q4, CI&T delivered strong top-line and bottom-line growth: revenue rose to $134.277M, up 19.61% YoY; net income rose to $14.568M, up 38.73% YoY; and EPS increased to $0.11, up 37.50% YoY. The main weakness was margin pressure, with gross margin falling to 32.26% from the prior year. Overall, the latest quarter shows healthy growth, but profitability quality is being pressured.
Analyst sentiment is mixed but improving. Wedbush started coverage with an Outperform and $9 target, which is bullish. UBS raised its target to $7.10 but kept a Neutral rating, while Canaccord raised its target to $7 and kept Buy. JPMorgan reduced its target to $6 and stayed Overweight, citing weak discretionary IT spending. Wall Street's bullish case is tied to AI/cloud demand and revenue growth, while the cautious view centers on spending softness and margin pressure. Overall, pros are somewhat more constructive than cons, but the stock is not yet getting a clean unanimous upgrade.
